Skip to main navigation

Overview
News Releases
Events & Presentations
Governance
Financials
- SEC Filings
Stock
- Stock Quote & Chart
- Analyst Coverage
IR Resources

Events & Presentations

Upcoming Events

More events are coming soon.

Presentations

Positive Longer-Term Durability and Safety Data of Miv-cel in SPS and gMG 4.3 MB

Investor Presentation - September 2026 6.4 MB

Kyverna AAN Conference Call Presentation 2.4 MB

KYSA-8 Topline Results for Stiff Person Syndrome 1 MB

KYSA-6 Phase 2 Interim Results for Myasthenia Gravis 793.4 KB

Neuroimmunology CAR T Franchise KOL Event Presentation - August 2025 6.6 MB

Past Events

Kyverna SPS and MG Longer-term Follow-up Data Conference Call

September 24, 2026 8:00 AM EDT

Click here for webcast

Positive Longer-Term Durability and Safety Data of Miv-cel in SPS and gMG 4.3 MB

H.C. Wainwright 28th Annual Global Investment Conference

September 15, 2026 11:30 AM EDT

Click here for webcast

Morgan Stanley 24th Annual Global Healthcare Conference

September 14, 2026 4:05 PM EDT

Click here for webcast

Wells Fargo 21st Annual Healthcare Conference

September 9, 2026 4:30 PM EDT

Click here for webcast

Jefferies Global Healthcare Conference

June 3, 2026 3:10 PM EDT

Click here for webcast

Kyverna - Jefferies Corporate Presentation 1.9 MB

H.C. Wainwright 4th Annual Nasdaq BioConnect Conference

May 19, 2026 2:30 PM EDT

Click here for webcast

Kyverna AAN Conference Call

April 22, 2026 4:00 AM PDT

Click here for webcast

Kyverna AAN Conference Call Presentation 2.4 MB

KYSA-8 Topline Results for Stiff Person Syndrome

December 15, 2025 8:00 AM EST

Click here for webcast

KYSA-8 Topline Results for Stiff Person Syndrome 1 MB

Kyverna Conference Call - KYSA-6 Phase 2 Interim Results for Myasthenia Gravis (MG)

October 29, 2025 8:00 AM EDT

Click here for webcast

Click here for Live Teleconference

KYSA-6 Phase 2 Interim Results for Myasthenia Gravis 793.4 KB

Virtual KOL Event - A Spotlight on Kyverna's Neuroimmunology CAR T Franchise

August 28, 2025 from 11:00 AM to 1:30 PM EDT

Click here for replay

Neuroimmunology CAR T Franchise KOL Event Presentation - August 2025 6.6 MB

Investor Contact

drafts InvestorRelations@kyvernatx.com

drafts Media@kyvernatx.com

phone_iphone +1 510.925.2492

Subscribe to our Email Alerts

© 2026 Kyverna Therapeutics

Social Media

LinkedIn opens in new window
Glassdoor opens in new window

Search Investors

Search this site